Sudal-12 Tannate Interactions
There are 495 drugs known to interact with Sudal-12 Tannate (chlorpheniramine / pseudoephedrine), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 23 are major, 466 are moderate, and 6 are minor.
- View all 495 medications that may interact with Sudal-12 Tannate
- View Sudal-12 Tannate alcohol/food interactions (1)
- View Sudal-12 Tannate disease interactions (10)
Most frequently checked interactions
View interaction reports for Sudal-12 Tannate (chlorpheniramine / pseudoephedrine) and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- albuterol
- Calcium 600 D (calcium / vitamin d)
- Celexa (citalopram)
- Ditropan (oxybutynin)
- Flagyl (metronidazole)
- lisinopril
- Mucinex DM (dextromethorphan / guaifenesin)
- multivitamin with minerals
- Pepcid AC Maximum Strength (famotidine)
- Robitussin Cold Cough and Flu (acetaminophen / dextromethorphan / guaifenesin / pseudoephedrine)
- tramadol
- Xanax (alprazolam)
- Xopenex (levalbuterol)
Sudal-12 Tannate alcohol/food interactions
There is 1 alcohol/food interaction with Sudal-12 Tannate (chlorpheniramine / pseudoephedrine).
Sudal-12 Tannate disease interactions
There are 10 disease interactions with Sudal-12 Tannate (chlorpheniramine / pseudoephedrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
Report options
More about Sudal-12 Tannate (chlorpheniramine / pseudoephedrine)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
